Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

NCT00909259 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.

NCT NCT00909259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00909259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing
Lead sponsor
Respicardia, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2013
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cheyne-stokes respiration, sleep apnea, sleep disordered breathing